New Key Statistics Module, Z-Score and F-Score
NAS:GYRE Key Ratios
| Market Cap $ M | 857.36 |
| Enterprise Value $ M | 869.36 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 15.96 |
| Price/Book | 13.55 |
| Price/Sales | 9.01 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 105.00 |
| EPS (TTM) $ | -1.27 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -69.90 |
| EV-to-EBIT | 83.78 |
| EV-to-EBITDA | 73.66 |
| PEG | -- |
| Shares Outstanding M | 85.82 |
| Net Margin (%) | -84.57 |
| Operating Margin % | 9.88 |
| Pre-tax Margin (%) | -74.10 |
| Quick Ratio | 3.29 |
| Current Ratio | 3.72 |
| ROA % (ttm) | -73.30 |
| ROE % (ttm) | -216.19 |
| ROIC % (ttm) | 15.04 |
| Dividend Yield % | -- |
| Altman Z-Score | 17.57 |
GYRE Number of Guru Trades
GYRE Volume of Guru Trades
Gurus Latest Trades with NAS:GYRE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:GYRE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Gyre Therapeutics Inc Insider Transactions
No Available Data
News about NAS:GYRE
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers